Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Obsessive-Compulsive Disorder
- Sponsor
- Shanghai Mental Health Center
- Enrollment
- 125
- Locations
- 1
- Primary Endpoint
- Changes in the diversity and composition of the microbiome before and after drug treatment.
- Status
- Enrolling By Invitation
- Last Updated
- last year
Overview
Brief Summary
This study aims to investigate the characteristics of the microbiota-gut-brain axis in pediatric patients with obsessive-compulsive disorder (OCD) through performing an integrated analysis of gut microbiota, serum metabolomics, neuroimaging and electroencephalography (EEG), conducted before and after treatment with selective serotonin reuptake inhibitors (SSRIs). The results will be compared with those of pediatric OCD paitents comorbid with tic disorder (TD) and healthy controls. The findings are expected to further elucidate the potential pathogenesis of OCD, providing a theoretical basis for identifying novel clinical intervention targets and optimizing treatment strategies.
Investigators
Zhen Wang
vice-president
Shanghai Mental Health Center
Eligibility Criteria
Inclusion Criteria
- •(1) 7-17 years old, (2) Y-BOCS score ≥16, (3) with or without a history of TD, (4) Drug-naïve or drug-free for 8 weeks, (5) Wechsler IQ score ≥ 80.
Exclusion Criteria
- •History of serious medical, neurological illness or other psychotic disorders other than OCD (tic disorder excepted).
- •Previous exposure to cognitive behavioral therapy (CBT) for OCD or TD.
- •serious suicide risk.
- •Has taken antibiotics, probiotics, prebiotics, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or immunosuppressants within the past 8 weeks.
- •Has a history of gastrointestinal diseases such as inflammatory bowel disease, irritable bowel syndrome, constipation, hemorrhoids, or a history of gastrointestinal surgery, or has a history of autoimmune diseases such as rheumatoid arthritis or systemic lupus erythematosus.
- •Participants with claustrophobic, heart pacemaker, mechanical heart valve, mechanical implant such as an aneurysm clip, hip replacement, or any other pieces of metal that have accidentally entered their body.
Outcomes
Primary Outcomes
Changes in the diversity and composition of the microbiome before and after drug treatment.
Time Frame: Before and after treatment with SSRIs for 12 weeks
The diversity (including alpha-diversity and beta-diversity) and composition will be measured in OCD patients and OCD patients with TD before and after drug treatment, and the results will be compared with those of healthy controls.